Floating Point — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Ataraxis develops AI foundation models that analyze multi-modal patient data, including pathology slide images, to assess cancer aggressiveness and predict recurrence risk and treatment response.
AI & Machine LearningBiotechHealthtechNew York, US
Jan Witowski(Co-founder (physician-scientist))inKrzysztof Geras(Co-founder)Jan Witowski MD PhD(Founder)in
BoardKrish Ramadural(Director)Rohan Ganeshananthan(Director)
Co-investorsAIX VenturesGiant Ventures Global LlpObvious VenturesTranspose Platform ManagementBertelsmann InvestmentsFounders Fund
Dandelion Health develops clinical AI applications by combining healthcare domain expertise with machine learning research to advance AI adoption in healthcare.
AI & Machine LearningDigital HealthHealthtechSyosset, US
Elliott Green(Executive Officer, Director)in
BoardSam Toole(Director)inNiyum Gandhi(Director)inSendhil Mullainathan(Director)Ziad Obermeyer
Co-investorsColle Capital PartnersHealthier CapitalMoxxie VenturesPrimary Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.